Interestingly in this study, Wu et al., found that the IL-17B/IL-17RB pathway supports tumorigenicity and metastasis formation of human pancreatic cancer cells through the activation of ERK1/2 signaling. This evidence concerns the gene IL17B and pancreatic neoplasm.